Peter Lamb, a partner in our Silicon Valley office, is a member of the Corporate Group. Peter advises both emerging and well established companies, with a focus on consumer-facing and technology companies.

His experience includes a wide range of M&A and growth equity financings for tech, life sciences and private equity clients. He has advised on the IPOs of companies such as Elevate Financial, Pandora Media, AVG Technologies, Portola Pharmaceuticals and ZS Pharma. Peter also advises a range of start-up clients on general corporate and financing matters.

Prior to joining Orrick, Peter was with Davis Polk & Wardwell.

  • Representative Clients

    • Warburg Pincus
    • Aptean
    • Twist Bioscience
    • Elasticsearch Global BV
    • Pinterest
    • Strike
    • Ladder Life
    • Janrain

    Selected Financings Engagement

    • AVG Technologies’ $128 million initial public offering and Pandora Media’s $235 million initial public offering.
    • Preferred stock financings, such as TangoMe on its Series D round, including $215 million from lead strategic investor Alibaba Group.

    Selected Mergers & Acquisitions

    • AVG in its $1.3 billion acquisition by Avast.
    • Micrel in its $840 million sale to Microchip.
    • Various add on acquisitions for Vista Equity Partners’ portfolio company Aptean
    • Shire’s asset sale of its Dermagraft business to Organogenesis.
    • Ingram Micro in its $840 million acquisition of BrightPoint.
    • Palm in its $1.2 billion sale to HP.
    • Vector Capital in its acquisition of Symantec’s application management business.

    Selected General Corporate Advisory

    • Public reporting, securities law compliance and corporate governance advice for companies like AVG Technologies, Anacor Pharmaceuticals, Ingram Micro, Pandora and Tango.

    Selected Pro Bono

    • Board Member, Youth Rights & Justice.
    • Various pro bono representations, including National Center for Youth Law and Microcredit Enterprises, a non-profit microfinance organization, in the negotiation of its credit agreement with the Overseas Private Investment Corporation (OPIC)